WORKING GROUP NAME: ANCA-Associated Vasculitis

This Composite Outcomes Workshop: Developing Response Criteria for
ANCA-Associated Vasculitis will bring to OMERACT a detailed real-world discussion of how to develop a composite outcome measure. The methods for creating a composite outcome are different than for individual domain-directed outcomes and this Workshop will help attendees understand the steps required for this process through a project that is funded by ACR and EULAR to create response criteria for ANCA-associated vasculitis for use in clinical trials. Attendees are encouraged before the Workshop to view the short but highly informative videos developed to inform everyone on the disease under study and the methods employed for this project.


OMERACT Endorsed Core Set of Outcome Measures for Clinical Trials in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Screen Shot 2020-09-17 at 8.49.39 PM


Screen Shot 2020-09-17 at 9.16.48 PM

Haner Direskeneli:

Screen Shot 2020-09-17 at 9.03.33 PM

Peter Merkel:

Screen Shot 2020-11-23 at 2.04.38 PM

Gunnar Tómasson:


bio photo (1)

Georgia Lanier


Screen Shot 2020-11-23 at 2.08.34 PM

Kaitlin Quinn


Sara Monti


Alibaz-Oner, Fatma
Aydin, Sibel
Björk, María
Cam, Esen
Christensen, Robin
Dejaco, Christian
Direskeneli, Haner 
Grayson, Peter 
Hatemi, Gülen 

Jayne, David
Kermani, Tanaz 
Langford, Carol
Lanier, Georgia
Mackie, Sarah  
Mahr, Alfred
Meara, Alexa 
Milman, Nataliya
Ozguler, Yesim 

Pagnoux, Christian
Robson, Joanna 
Shea, Beverly
Tómasson, Gunnar 
Merkel, Peter
Milman, Nataliya 
Monti, Sara 
Quinn, Kaitlin 
Tugwell, Peter